Bases moleculares y celulares de enfermedades inflamatorias/autoinmunes
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (212)
2024
-
Biodegradable polydioxanone stents: histologic and structural effects in an experimental model of tracheal stenosis
European Journal of Cardio-thoracic Surgery , Vol. 65, Núm. 4
-
Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?
Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78
-
Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study
Lupus
2023
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
Disease control in patients with ankylosing spondylitis in real clinical practice in Spain: Results of the MIDAS study
Reumatologia Clinica, Vol. 19, Núm. 2, pp. 99-105
-
Disease control in patients with psoriatic arthritis in real clinical practice in Spain: MiDAS study
Reumatologia Clinica, Vol. 19, Núm. 4, pp. 204-210
-
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Viruses, Vol. 15, Núm. 7
-
Gender biases in Spanish rheumatology: Perception and facts
Reumatologia Clinica, Vol. 19, Núm. 7, pp. 392-401
-
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 61
-
Searching for a prognostic index in lupus nephritis
European journal of medical research, Vol. 28, Núm. 1, pp. 19
-
mTOR inhibitors in a patient with lupus nephritis; why not?
Nefrologia
-
mTOR inhibitors in a patient with lupus nephritis; why not?
Nefrologia
2022
-
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
International Journal of Infectious Diseases, Vol. 117, pp. 56-64
-
Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
Seminars in Arthritis and Rheumatism, Vol. 52
-
Evidence of telomere attrition and a potential role for DNA damage in systemic sclerosis
Immunity and Ageing, Vol. 19, Núm. 1
-
Histological and structural effects of biodegradable polydioxanone stents in the rabbit trachea
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, Vol. 62, Núm. 2
-
Importance of family planning in patients with immune-mediated inflammatory diseases: a multidisciplinary approach
Reumatologia Clinica, Vol. 18, Núm. 4, pp. 200-206
-
Profibrotic Role of Inducible Heat Shock Protein 90α Isoform in Systemic Sclerosis
Journal of immunology (Baltimore, Md. : 1950), Vol. 209, Núm. 1, pp. 38-48
-
SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection
Annals of the Rheumatic Diseases, Vol. 81, Núm. 9, pp. 1337-1338
-
Saving the kidneys in the lupus patient: Beyond immunosuppression, the need to collaborate across multiple disciplines
European Journal of Internal Medicine, Vol. 99, pp. 19-21